Spanish Red Biotech Pipeline

MSD

Pembrolizumab /7684A

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Study of MK-7684A plus Chemotherapy versus Pembrolizumab plus Chemotherapy as First Line Treatment for Participants With Metastatic Non-Small Cell Lung Cancer
Phase: 3Phase III in Spain, 2Phase II, 1Phase I